Article Details
Retrieved on: 2024-08-23 21:00:34
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Cronos Group Inc.’s Q2 2024 financial results and global expansion initiatives, particularly in medical cannabis. It highlights revenue growth in markets including Canada, Israel, Germany, and the UK, and investments in the Cronos GrowCo venture to enhance their cannabis supply chain. Related Tags: 'Cronos, Cannabis, Conrad Lant, Brand, Germany, Cronos Group Inc., United States, Canada, United Kingdom, Israel'
Article found on: investingnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here